China
Africa
Explore chapters and articles related to this topic
Clinical Pharmacy and Its Relationship to Clinical Research
Published in Gary M. Matoren, The Clinical Research Process in the Pharmaceutical Industry, 2020
William F. McGhan, Glen L. Stimmel, Gary M. Matoren
The role that the clinical pharmacist plays in hospitals as the expert on drug therapy has been compared to the role of clinical pharmacologists. Some individuals have felt that clinical pharmacists have been very successful because they are more abundant (and less expensive) than clinical pharmacologists. As for maximizing the role of clinical pharmacists in clinical drug investigations, it should be pointed out that clinical pharmacists have many of the necessary skills and this could relieve some of the burdens placed on clinical pharmacologists [14].
Pharmacological Treatment Approaches
Published in Andrea Kohn Maikovich-Fong, Handbook of Psychosocial Interventions for Chronic Pain, 2019
Catherine G. Derington, David K. Choi, Katy E. Trinkley
To work toward these treatment goals, clinical pharmacists often are part of interdisciplinary treatment teams. Clinical pharmacists serve as experts in the appropriate selection, dosing, monitoring, and alteration of medication management plans. Pharmacists also provide clinical expertise in medication taper schedules, interpretation of urine drug screens, drug–drug interactions, drug–disease interactions, recognition and management of drug-related adverse effects, and risk mitigation strategies. Pharmacist involvement may vary from a clinical pharmacist present within the clinic providing on-site consultations, patient education, and patient care (most preferred) to a dispensing pharmacist in an off-site pharmacy dispensing medications in a retail or community setting. Depending upon the state, clinical pharmacists can enter collaborative practice agreements with primary pain management providers and see patients (similar to advanced nurse practitioners and physician assistants).
The Pharmacist
Published in William N. Kelly, Pharmacy, 2018
For pharmacists to fulfill their role as caregiver, they must be clinicians.24 A clinician in pharmacy is called a clinical pharmacist. Being a clinician requires knowledge of disease (anatomy, physiology, and pathology); drug therapy (medicinal chemistry, pharmacology, and therapeutics); and drug literature evaluation (drug information, research design, and biostatistics) and being able to understand and talk with patients (psychology and communication). This knowledge is used to assess patients and advise physicians and other health practitioners on drug selection, proper dosage, interactions, and side effects and how properly to monitor the drug.
Medication management for complex patients in primary care: application of a remote, asynchronous clinical pharmacist model
Published in Postgraduate Medicine, 2021
Mark Benson, David Murphy, Lindsey Hall, Philip Vande Kamp, David J Cook
The results of this feasibility study demonstrate the important role clinical pharmacists play in the healthcare team. Through individual engagement and assessment, pharmacists were able to optimize medication therapy of participating individuals. Our study is notable for an exceptional engagement rate. Our outbound call to reach rate was high at 68%. Subsequently, when members were reached by phone the consent rate was 83%. Importantly, common barriers to telephonic engagement such as incorrect, or out of service phone numbers were not experienced in this study. Initial phone numbers were provided by the insurance plan; however, if numbers were inoperable, we used the contact information available to the primary care team because of access to the EMR. This speaks to the importance of shared efforts on communication.
Potential Psychotropic Drug Interactions among Drug-dependent People
Published in Journal of Psychoactive Drugs, 2021
Diego Zapelini do Nascimento, Gabriela Moreno Marques, Fabiana Schuelter-Trevisol
This study presented alternatives for identifying drug interactions between adverse reactions, and demonstrated their impact related to the difficulty healthcare professionals encounter in dealing with psychotropic drugs. It is important to go beyond the identification of the patient’s clinical profile, and acquire knowledge of pharmacology, pharmacokinetics, and pharmacodynamics in order to promote the rational use of psychotropic drugs. That is the most effective way to identify potential drug interactions, as well as to properly manage potential adverse drug reactions that may be triggered by the use of several psychotropic drugs. The implementation of clinical pharmacy services in outpatient clinics, hospitals, and mental health-care centers can be considered the most effective alternative to avoid adverse reactions, including drug interactions, because the clinical pharmacist is qualified for such practice. In addition, pharmacists are ready to assist the entire multidisciplinary team involved in the treatment of patients with mental disorders or substance dependence, and provide pharmacological treatment.
Evaluating the role of clinical pharmacists in pre-procedural anticoagulation management
Published in Hospital Practice, 2018
Akash Kataruka, Elizabeth Renner, Geoffrey D. Barnes
In addition to the variation in the decision-maker for periprocedural anticoagulation, there exists variation in the estimation of thrombotic risk and knowledge of procedure-specific bleeding risk [9,19]. In contemporary practice, patients often receive bridging anticoagulation irrespective of thrombotic risk [4]. In the VTE population, bridging anticoagulation is provided to one-third of low- to moderate-risk patients while bridging anticoagulation is omitted on one-third of high-risk patients [20]. Among the AF population, no difference in the rates of CHADS2 score ≥2 or CHA2DS2-VASc score ≥2 in patients receiving bridging therapy was identified [21]. Superimposed on the varied estimation of thrombotic risk is the unnecessary interruption of VKA and use of bridging anticoagulation for low-risk procedures [22]. These inconsistencies in clinical practice expose patients to undue risk, resulting in increased bleeding, health-care costs, and hospital length of stay [23–25]. Clinical pathways and systematic protocols can standardize clinical practice [26]. Our study suggests that clinical pharmacists can serve an integral role in standardizing the management of periprocedural anticoagulation and provide a clinical pathway to improve quality of anticoagulation.